Cargando…

Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis

Synthetic cannabinoid receptor agonists (SCRAs) may be used as an alternative to natural cannabis; however, they may carry a greater risk of problematic use and withdrawal. This study aimed to characterise the withdrawal symptom profile of SCRAs and compare their profile of effect with high-potency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Craft, Sam, Ferris, Jason A., Barratt, Monica J., Maier, Larissa J., Lynskey, Michael T., Winstock, Adam R., Freeman, Tom P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110517/ https://www.ncbi.nlm.nih.gov/pubmed/34533608 http://dx.doi.org/10.1007/s00213-021-05945-1

Ejemplares similares

Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
por: Freeman, T. P., et al.
Publicado: (2015)

Cannabis use patterns at the dawn of US cannabis reform
por: Kumar, Navin, et al.
Publicado: (2019)

No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit
por: Hindocha, Chandni, et al.
Publicado: (2016)

Comparing intentions to reduce substance use and willingness to seek help among transgender and cisgender participants from the global drug survey
por: Connolly, Dean, et al.
Publicado: (2021)

Increasing potency and price of cannabis in Europe, 2006–16
por: Freeman, Tom P., et al.
Publicado: (2019)

Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis
por: Mensen, Vincent T., et al.
Publicado: (2019)

Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
por: Swift, Wendy, et al.
Publicado: (2013)

Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis
por: Bahji, Anees, et al.
Publicado: (2020)

Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence
por: Hines, Lindsey A., et al.
Publicado: (2020)

Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020)

The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
por: Jackson, Melissa A., et al.
Publicado: (2021)

Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis
por: Schoeler, Tabea, et al.
Publicado: (2022)

Moving on From Representativeness: Testing the Utility of the Global Drug Survey
por: Barratt, Monica J, et al.
Publicado: (2017)

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses
por: Lawn, Will, et al.
Publicado: (2016)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Medicinal use of cannabis based products and cannabinoids
por: Freeman, Tom P, et al.
Publicado: (2019)

Critical Illness Secondary to Synthetic Cannabinoid Ingestion
por: Kourouni, Ismini, et al.
Publicado: (2020)

Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department
por: Razban, Mohammad, et al.
Publicado: (2022)

Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice
por: Margiani, Giulia, et al.
Publicado: (2022)

Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegans
por: Reis Rodrigues, Pedro, et al.
Publicado: (2016)

The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review
por: Cohen, Koby, et al.
Publicado: (2018)

Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates
por: Manthey, Jakob, et al.
Publicado: (2021)

Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act
por: Craft, Sam, et al.
Publicado: (2022)

Delirium and High Creatine Kinase and Myoglobin Levels Related to Synthetic Cannabinoid Withdrawal
por: Yazici, Ahmet Bulent, et al.
Publicado: (2017)

Height, but not binding epitope, affects the potency of synthetic TCR agonists
por: Wilhelm, Kiera B., et al.
Publicado: (2021)

Height, but not binding epitope, affects the potency of synthetic TCR agonists
por: Wilhelm, Kiera B., et al.
Publicado: (2021)

Author Correction: The intersection between spliff usage, tobacco smoking, and having the first joint after waking
por: Kumar, Navin, et al.
Publicado: (2020)

The Intersection between Spliff Usage, Tobacco Smoking, and Having the First Joint after Waking
por: Kumar, Navin, et al.
Publicado: (2020)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countries
por: Davies, Emma L., et al.
Publicado: (2022)

Influence of the Synthetic Cannabinoid Agonist on Normal and Inflamed Cartilage: An In Vitro Study
por: Shang, Jiangyinzi, et al.
Publicado: (2023)

Cannabis, cannabinoids, and health
por: Lafaye, Genevieve, et al.
Publicado: (2017)

The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review
por: Takakuwa, Kevin M., et al.
Publicado: (2021)

Clinical management of cannabis withdrawal
por: Connor, Jason P., et al.
Publicado: (2022)

Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting
por: May, Benedict, et al.
Publicado: (2019)

Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users
por: Demirkıran, Aykut, et al.
Publicado: (2018)

Introduction to Cannabis and Cannabinoid Research
por: Piomelli, Daniele
Publicado: (2016)

The nephrologist's guide to cannabis and cannabinoids
por: Rein, Joshua L.
Publicado: (2020)

Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
por: Abrams, Donald I.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j21f4ldj6rikpvbcglb3q8jfnv